cervical CIN1 lesions and/or high-risk HPV infection
Conditions
Interventions
experimental group:After the end of menstruation every month, this product should be placed in the posterior fornix of the vagina with the drug delivery device. Use 1 tablet each time before going to
control group:blank control
Sponsors
Shandong Provincial Hospital
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1.Women aged between 18 and 65 at the time of screening (including thresholds) who are sexually active and non-pregnant and non-lactating 2.CIN1 and/or cervical infection with at least one high-risk HPV (type 16, 18 or other classification) during the screening period or within 3 months prior to screening. 3.Can adhere to complete the course of treatment, agree to participate in the study during effective contraception 4.During the study period, do not use other treatment methods
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating women. 2. The researcher and his/her immediate family members (immediate family members are defined as the researcher's current spouse, parents, biological or adopted children (including children from previous marriages), grandparents and grandchildren living in the researcher's home). 3. The results of TCT were high-grade intraepithelial lesions. 4. Combined with a variety of vaginitis, or acute, subacute pelvic inflammatory disease. 5. Combined with acuteness wet wart. 6. Having a birth plan within 1 year or within 6 months after delivery. 7. Smoking patients. 8. Allergy to interferon or excipients in the product. 9. Use of drugs that have not been officially approved within 30 days before enrollment. 10. The investigator considered a lack of medical or psychological risk preparation for the drug treatment under study. 11. One drug clinical study was added within 28 days before enrollment. 12. Have completed or withdrawn from this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cervical samples showed no high-risk HPV; | — |
Countries
China
Contacts
Public ContactChang-zhong li
Outcome results
None listed